Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00733954 · ClinicalTrials.gov registry record · Phase 4
Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis
A Phase 4 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 250
- Enrollment target
NCT00733954 is a Phase 4 study that has completed, run by Galderma R&D. The registered enrollment target is 250 participants.
The verdict
NCT00733954, a Phase 4 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 250 participants
- Enrollment target
Study Summary
This study is a comparison between Clobetasol Propionate Spray and Clobetasol Propionate Ointment with Regard to Efficacy, Safety, Subject Satisfaction and Duration of Response in Moderate to Severe Stable Plaque Psoriasis. Subjects will be enrolled and randomized into one of two groups: clobetasol propionate Spray for 4 weeks of treatment or clobetasol propionate ointment for 2 weeks of treatment with a 2 week follow-up visit for each group.
Interventions
- DRUG clobetasol propionate spray
- DRUG clobetasol propionate ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00733954
The ClinicalTrials.gov registry entry for NCT00733954 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which clobetasol propionate spray is the first listed.
NCT00733954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00733954 about?
NCT00733954 is a clinical study titled "Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis". This study is a comparison between Clobetasol Propionate Spray and Clobetasol Propionate Ointment with Regard to Efficacy, Safety, Subject Satisfaction and Duration of Response in Moderate to Severe Stable Plaque Psoriasis. Subjects will be enrolled and randomized into one of two groups: clobetasol ...
What is the current status of trial NCT00733954?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 250 participants. The study started on 2007-08. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00733954?
The interventions under investigation include: clobetasol propionate spray (DRUG), clobetasol propionate ointment (DRUG).
Who is sponsoring clinical trial NCT00733954?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.